I tried Ozempic and lost three stone. But was I at risk?

When financial analyst Emily Field was asked by Barclays to predict the likely economic implications of the new generation of weight-loss drugs, she came back with a surprising answer: it will be comparable to the invention of the smartphone. People have been gaining weight for 40 years, with the global obesity rate tripling since 1975 – but this trend now appears likely to be reversed. These new drugs, which work in a very different way from previous weight loss drugs, cause remarkable levels of weight loss: for Ozempic and Wegovy, people lose an average of 15 percent of their body weight in a year, while for new drugs ultimately come in, it’s a staggering 24 percent. As these drugs become